Acadian Asset Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,932
| Closed | -$180K | – | 1804 |
|
|
2025
Q1 | $180K | Sell |
22,932
-7,871
| -26% | -$61.8K | ﹤0.01% | 1274 |
|
|
2024
Q4 | $458K | Buy |
30,803
+29,507
| +2,277% | +$439K | ﹤0.01% | 1094 |
|
|
2024
Q3 | $19K | Buy |
+1,296
| New | +$19K | ﹤0.01% | 1983 |
|
|
2023
Q2 | – | Sell |
-1,444
| Closed | -$26K | – | 1878 |
|
|
2023
Q1 | $26K | Hold |
1,444
| – | – | ﹤0.01% | 1623 |
|
|
2022
Q4 | $29K | Buy |
+1,444
| New | +$29K | ﹤0.01% | 1660 |
|
|
2021
Q3 | – | Sell |
-5,022
| Closed | -$137K | – | 1964 |
|
|
2021
Q2 | $137K | Sell |
5,022
-3,576
| -42% | -$97.6K | ﹤0.01% | 1549 |
|
|
2021
Q1 | $241K | Buy |
8,598
+5,938
| +223% | +$166K | ﹤0.01% | 1437 |
|
|
2020
Q4 | $69K | Buy |
+2,660
| New | +$69K | ﹤0.01% | 1859 |
|
|
2020
Q3 | – | Sell |
-954
| Closed | -$24K | – | 2321 |
|
|
2020
Q2 | $24K | Sell |
954
-2,079
| -69% | -$52.3K | ﹤0.01% | 2102 |
|
|
2020
Q1 | $42K | Buy |
+3,033
| New | +$42K | ﹤0.01% | 1539 |
|
|
2019
Q4 | – | Sell |
-7,708
| Closed | -$70K | – | 2028 |
|
|
2019
Q3 | $70K | Buy |
+7,708
| New | +$70K | ﹤0.01% | 1562 |
|